Skip to main content
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.81
-0.16 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
5.76
-0.05 (-0.86%)
After-hours: Mar 28, 2025, 7:59 PM EDT

Recursion Pharmaceuticals Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Operating
64.60M 48.62M 45.23M 43.88M 46.93M 49.88M 46.52M 39.68M
Operating Growth
37.66% -2.52% -2.76% 10.57% 64.63% 177.85% 263.43% 296.81%
Grant
- 1.01M 1.00M 699.00K 432.00K 1.11K - -
Grant Growth
- 91,498.92% - - 390.31% -99.09% - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.